Von Eschenbach Nomination Criticized By Conservatives Over Plan B Switch
This article was originally published in The Tan Sheet
Executive Summary
The nomination of Andrew von Eschenbach to FDA full commissioner is now being challenged by conservatives, in reaction to the agency's reconsideration of Barr Labs' switch application for emergency contraceptive Plan B
You may also be interested in...
EC Foes Cite Study Showing More Access Fails To Cut Abortions, Pregnancies
Increased access to emergency contraception (EC) is not reducing unintended pregnancy rates, and further research is needed to determine how best to yield a public benefit from EC access, a meta-analysis finds
EC Foes Cite Study Showing More Access Fails To Cut Abortions, Pregnancies
Increased access to emergency contraception (EC) is not reducing unintended pregnancy rates, and further research is needed to determine how best to yield a public benefit from EC access, a meta-analysis finds
EC Foes Cite Study Showing More Access Fails To Cut Abortions, Pregnancies
Increased access to emergency contraception (EC) is not reducing unintended pregnancy rates, and further research is needed to determine how best to yield a public benefit from EC access, a meta-analysis finds